Logo for Roquefort Therapeutics PLC

Roquefort Therapeutics Investor Relations Material

Latest events

Logo for Roquefort Therapeutics

H2 2024

29 Apr, 2025
Logo for Roquefort Therapeutics

H1 2024

27 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Roquefort Therapeutics PLC

Access all reports
Roquefort Therapeutics PLC is a United Kingdom-based biotechnology company focused on developing novel therapies targeting cancer and autoimmune diseases. The company specializes in discovering and advancing small molecule and RNA-based therapeutics through its proprietary platforms. Its operations span early-stage research, preclinical testing, and strategic collaborations for drug development. Roquefort Therapeutics PLC is headquartered in London, United Kingdom, and its shares are listed on the LSE.